Summary:
- This article presents a significant advancement in the application of artificial intelligence for clinical oncology, specifically focusing on the use of deep learning models to predict immunotherapy response from histopathology images.
- The research demonstrates that computational pathology can identify spatial biomarkers within the tumor microenvironment that correlate with patient outcomes, offering a potential tool to augment precision medicine and guide therapeutic decision-making.